Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04924322 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

Study acronym: CRETE
StatusRecruiting
PhasePhase 2/3
Started2022-05-11
View on ClinicalTrials.gov ↗

Amendment history

2026-06-04
minor
Study Status, Oversight, IPDSharing v25
Primary completion date2026-04-30→2027-04-30
Completion date2026-07-31→2027-08-31
2025-06-05
minor
Study Status, Contacts/Locations v24
Study sites21→22
2025-03-12
minor
Study Identification, Study Status, Contacts/Locations v23
Study sites20→21
Study titlerevised
Catheter-Related Early Thromboprophylaxis withWith Enoxaparin Studies
2025-01-29
minor
Study Status, Contacts/Locations v22
Study sites19→20
2025-01-02
minor
Study Status, Contacts/Locations v21
Study sitesdetails revised at 1 of 19 sites
Show 20 earlier versions
2024-12-18
minor
Study Identification, Study Status, Sponsor/Collaborators, Oversight, Contacts/Locations, IPDSharing v20
Study sites17→19
Study titlerevised
Catheter-Related Early Thromboprophylaxis Withwith Enoxaparin Studies
2024-10-21
minor
Study Status, Sponsor/Collaborators, Contacts/Locations v19
Study sites16→17
Collaborators15 to 16 entries
VirginiaChildren's CommonwealthHospital Universityof Illinois at Peoria Hassenfeld Children's Hospital
2024-08-08
minor
Study Status, Contacts/Locations v18
Study sitesdetails revised at 6 of 16 sites
2023-11-20
minor
Study Status, Contacts/Locations v17
Study sitesdetails revised at 4 of 16 sites
2023-05-31
minor
Study Status, Contacts/Locations v16
Study sites15→16
2023-04-21
minor
Study Status, Contacts/Locations v15
Study sitesdetails revised at 1 of 15 sites
2023-03-23
minor
Study Status, Contacts/Locations v14
Study sitesdetails revised at 1 of 15 sites
2023-02-28
minor
Study Identification, Study Status, Sponsor/Collaborators v13
Collaborators14 to 15 entries
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
2023-02-02
minor
Study Status, Contacts/Locations v12
Study sitesdetails revised at 4 of 15 sites
2023-01-23
minor
Study Status, Sponsor/Collaborators, Contacts/Locations v11
Study sitesdetails revised at 3 of 15 sites
Collaborators15 to 14 entries
Children's Hospital Medical Center, Cincinnati
2022-12-12
minor
Study Status, Contacts/Locations v10
Study sitesdetails revised at 2 of 15 sites
2022-11-17
minor
Study Status, Contacts/Locations v9
Study sites14→15
2022-11-03
minor
Study Status, Contacts/Locations v8
Study sitesdetails revised at 1 of 14 sites
2022-10-27
minor
Study Status, Sponsor/Collaborators, Contacts/Locations v7
Study sites14 entries, revised
Johns Hopkins All Children's Healthcare of Atlanta, Egleston
Collaborators14 to 15 entries
Johns Hopkins All Children's HealthcareHospital University of AtlantaOklahoma
2022-09-27
minor
Study Status, Contacts/Locations v6
Study sites15→14
2022-06-01
minor
Study Status, Contacts/Locations v5
Study sitesdetails revised at 2 of 15 sites
2022-05-11
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v4
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2022-05-01→confirmed 2022-05-11
Study sitesdetails revised at 15 of 15 sites
2022-04-07
minor
Study Status v3
Start date2022-02-15→2022-05-01
2022-02-02
minor
Study Status v2
Start date2022-01-01→2022-02-15
2021-09-24
minor
Study Status, Study Description, Outcome Measures v1
Secondary endpoints6 entries, revised
AnyNumber of children with any VTE ClinicallyNumber of children with clinically apparent CADVT ClinicallyNumber of children with clinically apparent VTE ClinicallyNumber of children with clinically relevant bleeding AnyNumber of children with any bleeding HeparinNumber of children with heparin-induced thrombocytopenia
Primary endpoints1 entry, revised
Number of children with CADVT
Study description+90 characters
[...] cause the hemostatic system changes significantly with age. WeThe investigators recently completed a Bayesian phase 2b randomized clinical trial. In this trial, wethe investigators randomized critically ill children to early administration [...] of CADVT in critically ill children. To achieve this goal, wethe investigators aim (1) to confirm the efficacy and safety of early adminis [...] n in reducing the risk of CADVT in critically ill children. WeThe investigators will conduct 2 multicenter Bayesian explanatory randomized [...] eding. Using plasma obtained from subjects in the 2 trials, wethe investigators wi [...] [...]
2021-06-07
minor
Original filing
487 trials monitored
See 35 trials at risk
The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.
Trial Details
NCT Number NCT04924322
Lead Sponsor Yale University
Collaborators: Children's Hospital Colorado, Children's Hospital of Philadelphia, BJC HealthCare, Medical College of Wisconsin, Children's of Alabama, Golisano Children's Hospital, Maria Fareri Children's Hospital, Nationwide Children's Hospital, New York Presbyterian Hospital, Penn State University, University of Iowa, Johns Hopkins All Children's Hospital, University of Oklahoma, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Children's Hospital of Illinois at Peoria, Hassenfeld Children's Hospital
Conditions Deep Venous Thrombosis
Enrollment 258 participants
Start Date 2022-05-11
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-08